In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally, we discuss a groundbreaking procedure in which a kidney from a CRISPR gene edited pig was transplanted into a human
Podcast Tags: healthcare, healthcare news, CVS health, PBMs, biosimilars, 340B, pharmacies, hospitals, providers, xenotransplantation, CRISPR, gene editing
Source Links:
- As Humira biosimilars take over the market, CVS has created a new ploy; the drug “rebate credit”
- Federal appeals court sides with 340B contract pharmacies
- American Hospital Association 340B Factsheet
- Gene edited pig kidney transplanted into a living patient for the first time
- Kidney Disease Statistics for the United States
Panel – Jen Burke, Mindy McGrath, Ryan Hummel
Research & Production – Anna Briccetti, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Featured Vynamic Team Members
About Vynamic
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Want to learn more? Get in touch!
Related Podcasts:
Direct by Design: Pharma’s Next Channel is the Patient
The traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift,...
Listen nowPharma, Meet Gen Z: The Generation Redefining Trust and Attention
As Gen Z steps into the healthcare workforce, they’re bringing new expectations for authenticity, technology, and...
Listen nowWe’re Gold Sponsors at Reuters Pharma Customer Engagement USA 2025
Join us Oct 28 at Reuters Pharma USA 2025 as Vynamic leads a CX panel with Pfizer, Takeda & AstraZeneca on scale, stability & innovation.
Read more